Loading...
In resource-limited areas, cryptococcal meningitis (CM) is a leading cause of HIV-associated death. Intravenous amphotericin B (AmB) plus oral 5-flucytosine (5FC) is considered the standard therapy, but cost and need for intravenous administration preclude widespread use in sub-Saharan Africa. Studies involving fluconazole (FLU) alone have shown some efficacy, and limited data suggest that adding 5FC to FLU might improve outcome.
In an open-label study conducted in Malawi, 44 adults with HIV infection and first-episode CM who were not receiving antiretroviral therapy were randomized to receive FLU (1200 mg daily) either alone or together with 5FC (100 mg/kg/day) for 14 days. Quantitative cerebrospinal fluid (CSF) fungal cultures of samples o…